Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MPLN Stock Forecast 2026-2027
$27.00
Current Price
$437.08M
Market Cap
Buy 1
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to MPLN Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
MPLN Price Momentum
+6.7%
1 Week Change
+66.3%
1 Month Change
+24.6%
1 Year Change
-36.8%
Year-to-Date Change
-63.5%
From 52W High of $74.07
+124.3%
From 52W Low of $12.04
📊 TOP ANALYST CALLS
Did MPLN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if MultiPlan is one of their latest high-conviction picks.
Latest MPLN Stock Price Targets & Analyst Predictions
MPLN has shown a year-to-date change of -36.8% and a 1-year change of 24.6%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MPLN. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MPLN Analyst Ratings
1
Buy
1
Hold
0
Sell
MPLN Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $27.00
Latest MPLN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MPLN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 10, 2025 | Piper Sandler | Neutral | Maintains | $N/A | |
| Jan 10, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $12.50 |
| Sep 23, 2024 | Citigroup | Daniel Grosslight | Neutral | Maintains | $10.00 |
| Aug 7, 2024 | Piper Sandler | Jessica Tassan | Neutral | Reiterates | $1.00 |
| Jun 26, 2024 | Piper Sandler | Jessica Tassan | Neutral | Initiates | $2.00 |
| Mar 8, 2023 | Citigroup | Daniel Grosslight | Neutral | Maintains | $1.25 |
| Jan 18, 2023 | Barclays | Marc Solecitto | Equal-Weight | Maintains | $1.00 |
| Dec 13, 2022 | Citigroup | Daniel Grosslight | Neutral | Downgrade | $2.00 |
| Nov 16, 2022 | Goldman Sachs | Cindy Motz | Neutral | Maintains | $2.05 |
| Nov 9, 2022 | Citigroup | Daniel Grosslight | Buy | Maintains | $3.00 |
| Jul 12, 2022 | Goldman Sachs | Cindy Motz | Neutral | Initiates | $6.50 |
| May 11, 2022 | Citigroup | Daniel Grosslight | Buy | Maintains | $6.50 |
| Dec 20, 2021 | Citigroup | Buy | Maintains | $7.00 | |
| Nov 11, 2021 | Barclays | Steve Valiquette | Equal-Weight | Maintains | $6.00 |
| Aug 20, 2021 | Tigress Financial | Buy | Initiates | $N/A | |
| Apr 7, 2021 | B. Riley FBR | Buy | Initiates | $N/A | |
| Apr 7, 2021 | B. Riley Securities | Buy | Initiates | $N/A | |
| Mar 19, 2021 | Barclays | Equal-Weight | Initiates | $N/A | |
| Nov 17, 2020 | Citigroup | Buy | Initiates | $N/A | |
| Nov 16, 2020 | Citigroup | Buy | Initiates | $N/A |
Claritev Corporation (MPLN) Competitors
The following stocks are similar to MultiPlan based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MPLN
MultiPlan
mkt cap
437.08M
Claritev Corporation (MPLN) Financial Data
Valuation Metrics
Market Cap
$437.08M
Enterprise Value
$4.96B
P/E Ratio
N/A
PEG Ratio
N/A
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
+0.7%
Gross Margin
+75.4%
Operating Margin
-155.2%
Net Margin
+74.3%
EPS Growth
-4.9%
Financial Health
Cash/Price Ratio
N/A
Current Ratio
0.8x
Debt/Equity
54.0x
ROE
-1,958.8%
ROA
-32.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Claritev Corporation (MPLN) Business Model
About Claritev Corporation
What They Do
Provides advanced technological solutions for data analytics.
Business Model
The company generates revenue by offering analytical tools and platforms that help businesses leverage data-driven insights. Its services cater to various industries, including finance, healthcare, and retail, enabling clients to transform raw data into actionable intelligence and improve their operational efficiency.
Additional Information
Claritev Corporation is committed to research and development, positioning itself as a leader in big data integration, artificial intelligence, and cloud computing. Its diverse clientele ranges from large corporations to startups, allowing it to play a crucial role in digital transformation across multiple sectors.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
3,000
CEO
Mr. Travis S. Dalton
Country
United States
IPO Year
2020
Website
www.claritev.comClaritev Corporation (MPLN) Latest News & Analysis
Latest News
Quick Summary
ClearNote Health's Avantect Pancreatic Cancer Test is now accessible to members of Claritev's national PHCS and MultiPlan Networks.
Why It Matters
ClearNote Health's Avantect test expanding access through major networks signals potential revenue growth and wider adoption, impacting stock performance and market confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Claritev Corporation (MPLN) has released its Q4 2024 earnings call transcript, providing insights into financial performance and strategic direction.
Why It Matters
The Q4 2024 earnings call provides insights into Claritev Corporation's financial performance, growth potential, and strategic direction, influencing stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025
1 year ago
Quick Summary
Claritev reported its Q4 and full year 2024 results and provided initial guidance for full year 2025.
Why It Matters
Claritev's Q4 and full-year results, along with 2025 guidance, provide insights into financial health and future expectations, influencing investor sentiment and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
MultiPlan Corporation (MPLN) reported a quarterly loss of $5.14 per share, worse than the expected loss of $2.33, and significantly higher than a loss of $2.40 per share from the previous year.
Why It Matters
MultiPlan's larger-than-expected quarterly loss signals worsening financial performance, potentially leading to decreased investor confidence and share price volatility.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Claritev Corporation (NYSE: MPLN) announced its analytics solution, BenInsights®, has achieved Oracle Cloud Expertise and is now available in the Oracle Cloud Marketplace, enhancing value for Oracle customers.
Why It Matters
Claritev's integration with Oracle Cloud enhances its market position and accessibility, potentially boosting revenue. This partnership could attract new customers and strengthen investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Claritev Corporation, formerly MultiPlan, announced a rebranding and will begin trading under the new ticker CTEV on the NYSE starting February 28, 2025.
Why It Matters
Claritev's rebranding and new ticker symbol indicate a strategic shift that may affect market perception and investor confidence, potentially impacting stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About MPLN Stock
What is Claritev Corporation's (MPLN) stock forecast for 2026?
Analyst forecasts for Claritev Corporation (MPLN) are not currently available. The stock is trading at $27.00.
Is MPLN stock a good investment in 2026?
According to current analyst ratings, MPLN has 1 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $27.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MPLN stock?
Price predictions from Wall Street analysts for MPLN are not currently available. The stock is trading at $27.00.
What is Claritev Corporation's business model?
The company generates revenue by offering analytical tools and platforms that help businesses leverage data-driven insights. Its services cater to various industries, including finance, healthcare, and retail, enabling clients to transform raw data into actionable intelligence and improve their operational efficiency.
What is the highest forecasted price for MPLN Claritev Corporation?
Price targets from Wall Street analysts for MPLN are not currently available. The stock is trading at $27.00.
What is the lowest forecasted price for MPLN Claritev Corporation?
Price targets from Wall Street analysts for MPLN are not currently available. The stock is trading at $27.00.
What is the overall MPLN consensus from analysts for Claritev Corporation?
The overall analyst consensus for MPLN is neutral. Out of 6 Wall Street analysts, 1 rate it as Buy, 1 as Hold, and 0 as Sell.
How accurate are MPLN stock price projections?
Stock price projections, including those for Claritev Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 11, 2026 3:02 PM UTC